Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BactiQuant A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   0.9% 1.1% 3.0% 4.5% 5.8% 4.9% 7.5% 7.5%   Credit score (0-100)   91 85 57 45 39 43 32 32   Credit rating   A A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   1,070.6 662.3 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 15,495 5,482 8,359 12,389 12,303 12,303 12,303   Gross profit   7,628 8,608 3,135 -2,955 -1,927 -756 0.0 0.0   EBITDA   2,057 3,477 -559 -11,807 -12,340 -9,494 0.0 0.0   EBIT   1,939 3,342 -1,287 -12,679 -13,677 -10,903 0.0 0.0   Pre-tax profit (PTP)   2,924.3 3,962.4 -1,290.4 -13,433.6 -14,184.5 -13,103.9 0.0 0.0   Net earnings   2,405.3 3,179.8 -981.7 -13,552.3 -14,184.5 -13,103.9 0.0 0.0   Pre-tax profit without non-rec. items   2,924 3,962 -1,290 -13,434 -14,185 -13,104 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   363 361 0.0 2,085 1,652 1,193 0.0 0.0   Shareholders equity total   10,640 12,768 8,966 14,307 14,307 14,412 11,562 11,562   Interest-bearing liabilities   0.0 0.0 0.0 0.0 3,838 7,788 0.0 0.0   Balance sheet total (assets)   12,359 14,819 10,714 24,518 23,179 25,503 11,562 11,562   Net Debt   -3,313 -2,426 -668 -10,442 219 -4,037 -11,562 -11,562     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 15,495 5,482 8,359 12,389 12,303 12,303 12,303   Net sales growth   0.0% 0.0% -64.6% 52.5% 48.2% -0.7% 0.0% 0.0%   Gross profit   7,628 8,608 3,135 -2,955 -1,927 -756 0.0 0.0   Gross profit growth   0.3% 12.9% -63.6% 0.0% 34.8% 60.8% 0.0% 0.0%   Employees   9 9 7 11 14 12 0 0   Employee growth %   50.0% 0.0% -22.2% 57.1% 27.3% -14.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,359 14,819 10,714 24,518 23,179 25,503 11,562 11,562   Balance sheet change%   11.6% 19.9% -27.7% 128.8% -5.5% 10.0% -54.7% 0.0%   Added value   2,057.5 3,477.4 -559.3 -11,807.1 -12,804.3 -9,494.3 0.0 0.0   Added value %   0.0% 22.4% -10.2% -141.2% -103.4% -77.2% 0.0% 0.0%   Investments   139 -114 5,019 1,265 -1,916 -2,278 -6,940 0   Net sales trend   0.0 0.0 -1.0 1.0 2.0 -1.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 22.4% -10.2% -141.2% -99.6% -77.2% 0.0% 0.0%   EBIT %   0.0% 21.6% -23.5% -151.7% -110.4% -88.6% 0.0% 0.0%   EBIT to gross profit (%)   25.4% 38.8% -41.1% 429.1% 709.9% 1,442.8% 0.0% 0.0%   Net Earnings %   0.0% 20.5% -17.9% -162.1% -114.5% -106.5% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 21.4% -4.6% -151.7% -103.7% -95.1% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 25.6% -23.5% -160.7% -114.5% -106.5% 0.0% 0.0%   ROA %   14.1% 22.6% -10.0% -71.6% -55.9% -40.0% 0.0% 0.0%   ROI %   30.4% 33.7% -11.4% -80.2% -67.7% -57.4% 0.0% 0.0%   ROE %   24.1% 27.2% -9.0% -116.5% -99.1% -91.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   86.1% 86.2% 83.7% 58.4% 63.6% 56.9% 100.0% 100.0%   Relative indebtedness %   0.0% 12.0% 31.9% 41.3% 71.6% 90.1% 0.0% 0.0%   Relative net indebtedness %   0.0% -3.7% 19.7% -83.6% 42.4% -6.0% -94.0% -94.0%   Net int. bear. debt to EBITDA, %   -161.0% -69.8% 119.5% 88.4% -1.8% 42.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 26.8% 54.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 28.9% 26.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.9 5.7 2.0 5.3 3.3 5.8 0.0 0.0   Current Ratio   6.0 7.2 3.2 6.5 3.6 6.8 0.0 0.0   Cash and cash equivalent   3,312.7 2,425.5 668.5 10,442.2 3,618.9 11,824.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 25.4 15.8 82.3 192.1 64.4 0.0 0.0   Trade creditors turnover (days)   0.0 80.5 345.9 79.3 91.8 80.2 0.0 0.0   Current assets / Net sales %   0.0% 77.7% 81.4% 188.2% 120.8% 147.2% 94.0% 94.0%   Net working capital   8,017.0 10,367.5 3,077.1 13,321.6 10,805.4 15,460.9 0.0 0.0   Net working capital %   0.0% 66.9% 56.1% 159.4% 87.2% 125.7% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 1,722 783 760 885 1,025 0 0   Added value / employee   229 386 -80 -1,073 -915 -791 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   229 386 -80 -1,073 -881 -791 0 0   EBIT / employee   215 371 -184 -1,153 -977 -909 0 0   Net earnings / employee   267 353 -140 -1,232 -1,013 -1,092 0 0